共 29 条
- [21] TARGETING COLD TUMORS USING IPSC-DERIVED CAR T CELLS DIRECTED TO THE IMMUNE CHECKPOINT MOLECULE AND TUMOR-ASSOCIATED ANTIGEN B7-H3JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A303 - A303Tuncel, Jon论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FTP1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAValamehr, Bahram论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAYuan, Xu论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAMartinez, Francisco论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USABrookhouser, Nicholas论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAChu, Philip论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAOzmadenci, Duygu论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USADavis, Zachary论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Fate Therapeut Inc FHQ1, San Diego, CA USABlum, Robert论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAHancock, Bryan论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAGaertner, Bjoern论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USA论文数: 引用数: h-index:机构:Sikaroodi, Shohreh论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAMeza, Miguel论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USADailey, Thomas论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAFelices, Martin论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Fate Therapeut Inc FHQ1, San Diego, CA USA论文数: 引用数: h-index:机构:Fong, Lauren论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USALee, Tom论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAClarke, Raedun论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USAGoulding, John论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USABjordahl, Ryan论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc FHQ1, San Diego, CA USA Fate Therapeut Inc FHQ1, San Diego, CA USA论文数: 引用数: h-index:机构:
- [22] iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferationMEDCOMM, 2024, 5 (05):Zhang, Yuxuan论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaShi, Qingxin论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaWang, Peiyun论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaHuang, Chujun论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaTang, Shuqing论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaZhou, Miaojin论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaHu, Qian论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaWu, Lingqian论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R ChinaLiang, Desheng论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China Cent South Univ, Sch Life Sci, Hunan Key Lab Anim Models Human Dis, Changsha, Peoples R China Cent South Univ, Ctr Med Genet & Hunan Key Lab Med Genet, Sch Life Sci, Changsha 410078, Peoples R China
- [23] Effect of iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the rDNA locus on anti-tumor activity and proliferation.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 175 - 175Liang, Desheng论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Changsha, Peoples R China Cent South Univ, Changsha, Peoples R ChinaZhang, Yuxuan论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Changsha, Peoples R ChinaShi, Qingxin论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Changsha, Peoples R ChinaHu, Qian论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Changsha, Peoples R ChinaWu, Lingqian论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Changsha, Peoples R China
- [24] OFF-THE-SHELF IPSC-DERIVED CAR-T CELLS CONTAINING SEVEN FUNCTIONAL EDITS OVERCOME ANTIGEN HETEROGENEITY, IMPROVE TRAFFICKING, AND WITHSTAND IMMUNOSUPPRESSION ASSOCIATED WITH FAILED TUMOR TREATMENTJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A319 - A319Hosking, Martin论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAShirinbak, Soheila论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAShrestha, Bishwas论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAGrant, Joy论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAOmilusik, Kyla论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAKeegan, Hannah论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USACardenas, Demetrio论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAGentile, Angela论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAChandra, Shilpi论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALoter, Lorraine论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALinderhof, Lexe论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USABrookhouser, Nicholas论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAKennedy, Stephanie论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAMartinez, Francisco论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USACampanati, Loraine论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAEcker, Chris论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAYuan, Xu论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAPalomares, Karina论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALai, Yi-Shin论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAFong, Lauren论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAPan, Yijia论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USASikaroodi, Shohreh论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAJelcic, Mark论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAChu, Philip论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAMehta, Amit论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USASmith, Layton论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAPeralta, Eigen论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALee, Tom论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAAbujarour, Ramzey论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAClarke, Raedun论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAValamehr, Bob论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USA
- [25] Chimeric fusion receptors provide a CD3-mediated activation signal to off-the-shelf iPSC-derived TCR-less CAR-T cells for enhanced efficacy.CANCER RESEARCH, 2021, 81 (13)Peralta, Eigen论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALu, Dan论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALandon, Mark论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAChu, Helen论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USASikaroodi, Shohreh论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USACarron, Emily论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USANavarrete, Natalie论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAWitty, Alec论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALee, Tom论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USANguyen, Anhco论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAValamehr, Bahram论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USA
- [26] TRI-MODAL CAR+TCR+HNCD16+ IPSC-DERIVED T CELLS CO-TARGETING SURFACE AND INTRACELLULAR/ NEOANTIGENS DEMONSTRATE ADDITIVE EFFECT ON OVERCOMING TUMOR HETEROGENEITY AND CANCER ESCAPEJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A315 - A315Yang, Bi-Huei论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAShirinbak, Soheila论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAYeh, Wen-I论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAGutierrez, Alma论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAPribadi, Mochtar论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAGaertner, Bjoern论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAChu, Hui-Yi论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAGonzalez, David论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALiao, Angela论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALee, Tom论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAPeralta, Eigen论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USABjordahl, Ryan论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAHosking, Martin论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAChang, Chia-Wei论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAValamehr, Bob论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USA
- [27] Chimeric CD3 fusion receptors expressed on iPSC-derived universal TCR-less CAR-T and -NK cells synergize with bispecific engagers to enhance antitumor activity and limit antigen escapeCANCER RESEARCH, 2022, 82 (12)Peralta, Eigen论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALu, Dan论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALandon, Mark论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAChu, Hui-Yi论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAMehta, Amit论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAChu, Philip论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAWitty, Alec论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USALee, Tom论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USAValamehr, Bahram论文数: 0 引用数: 0 h-index: 0机构: Fate Therapeut Inc, San Diego, CA USA Fate Therapeut Inc, San Diego, CA USA
- [28] Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in MiceINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)Pfeifer, Rita论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyAl Rawashdeh, Wa'el论文数: 0 引用数: 0 h-index: 0机构: Ossium Hlth Inc, Indianapolis, IN 46278 USA Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyBrauner, Janina论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyMartinez-Osuna, Manuel论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyLock, Dominik论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyHerbel, Christoph论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyEckardt, Dominik论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyAssenmacher, Mario论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyBosio, Andreas论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyHardt, Olaf T.论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, GermanyJohnston, Ian C. D.论文数: 0 引用数: 0 h-index: 0机构: Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany
- [29] Adoptive Immunotherapy Following Umbilical Cord Blood Transplantation Using The Sleeping Beauty System and Artificial Antigen Presenting Cells To Generate Donor-Derived T Cells Expressing a CD19-Specific Chimeric Antigen ReceptorBLOOD, 2013, 122 (21)Kebriaei, Partow论文数: 0 引用数: 0 h-index: 0Huls, Helen论文数: 0 引用数: 0 h-index: 0Singh, Harjeet论文数: 0 引用数: 0 h-index: 0Olivares, Simon论文数: 0 引用数: 0 h-index: 0Figliola, Matthew论文数: 0 引用数: 0 h-index: 0Kumar, Pappanaicken R.论文数: 0 引用数: 0 h-index: 0Jena, Bipulendu论文数: 0 引用数: 0 h-index: 0Jackson, Rineka N.论文数: 0 引用数: 0 h-index: 0Liu, Tingting论文数: 0 引用数: 0 h-index: 0McNiece, Ian K.论文数: 0 引用数: 0 h-index: 0Rondon, Gabriela论文数: 0 引用数: 0 h-index: 0Hackett, Perry论文数: 0 引用数: 0 h-index: 0Champlin, Richard E.论文数: 0 引用数: 0 h-index: 0Shpall, Elizabeth J.论文数: 0 引用数: 0 h-index: 0Cooper, Laurence J. N.论文数: 0 引用数: 0 h-index: 0